report banner
EWG HOME   |   TEST RESULTS   |   REPORT CONTENTS  


test results
guest commentary content index peer statement



FULL REPORT

 

News Release

1: Executive summary

2: Babies are vulnerable to chemical harm

3: Human health problems on the rise

4: Recommendations



 

Detailed findings

Methodology

Questions and Answers

References

About This Report

Printer-Friendly Version (PDF)

Related News Coverage

Related EWG Investigations



RELATED DOCUMENTS

 

News Release: CDC Petition (21 July)

EWG Ltr to Chemical Companies (21 July)

EWG Letter to Chemical Lobby (PDF)

Chemical Lobby Response #1 (PDF)

Follow-Up Letter to Chemical Lobby (21 July)

Stmt from US Rep. Slaughter (PDF)

Stmt from Minority Leader Pelosi (PDF)




Support EWG - Donate Now



THE LATEST ON BODY BURDEN
Newsfeed from
Environmental Health News

 

 

Printable Version of This Page

 

Search www.ewg.org

Provided by Google

 

 

 
periodic graphic

  2,3,4,7,8-PeBDF (pentafuran)

2,3,4,7,8-PeBDF (pentafuran) was found in 6 of 10 umbilical cord blood samples from babies born in U.S. hospitals in 2004, at concentrations ranging from 0.8 to 21.4 pg/g (lipid weight, in whole blood). It was also found in 1 of 3 adult blood samples, at a concentration of 2.8 pg/g (lipid weight, in whole blood).


About 2,3,4,7,8-PeBDF (pentafuran)
CAS RN131166-92-2
Chemical ClassBrominated furan
Chemical SubClassPentabrominated furan
Usesno commercial uses, pollution from incineration of products containing brominated fire retardants



Priority Health Concerns for 2,3,4,7,8-PeBDF (pentafuran)
Health Concern or Target OrganWeight of Evidence
Immune SystemProbable Effects

References for Health Effects



Suspected Health Concerns for 2,3,4,7,8-PeBDF (pentafuran)
Cancer, Birth Defects / Developmental Delays, Cardiovascular System Or Blood, Hormone System, Stomach Or Intestines, Kidney, Brain, Nervous System, Reproductive System, Female Reproductive System, Male Reproductive System, Lungs/breathing, Hearing, Skin

References for Health Effects